Personal CFO Solutions’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-14,238
| Closed | -$356K | – | 553 |
|
|
2024
Q3 | $356K | Hold |
14,238
| – | – | 0.05% | 350 |
|
|
2024
Q2 | $266K | Hold |
14,238
| – | – | 0.04% | 425 |
|
|
2024
Q1 | $281K | Hold |
14,238
| – | – | 0.04% | 416 |
|
|
2023
Q4 | $250K | Hold |
14,238
| – | – | 0.04% | 423 |
|
|
2023
Q3 | $247K | Hold |
14,238
| – | – | 0.05% | 378 |
|
|
2023
Q2 | $200K | Hold |
14,238
| – | – | 0.04% | 447 |
|
|
2023
Q1 | $153K | Hold |
14,238
| – | – | 0.03% | 456 |
|
|
2022
Q4 | $213K | Hold |
14,238
| – | – | 0.05% | 404 |
|
|
2022
Q3 | $183K | Sell |
14,238
-1,000
| -7% | -$12.9K | 0.05% | 383 |
|
|
2022
Q2 | $148K | Sell |
15,238
-2,000
| -12% | -$19.4K | 0.03% | 409 |
|
|
2022
Q1 | $171K | Hold |
17,238
| – | – | 0.03% | 445 |
|
|
2021
Q4 | $203K | Sell |
17,238
-5,000
| -22% | -$58.9K | 0.04% | 442 |
|
|
2021
Q3 | $253K | Sell |
22,238
-4,300
| -16% | -$48.9K | 0.05% | 352 |
|
|
2021
Q2 | $370K | Buy |
26,538
+300
| +1% | +$4.18K | 0.08% | 236 |
|
|
2021
Q1 | $486K | Hold |
26,238
| – | – | 0.11% | 181 |
|
|
2020
Q4 | $464K | Buy |
26,238
+4,538
| +21% | +$80.3K | 0.11% | 177 |
|
|
2020
Q3 | $0 | Buy |
21,700
+2,000
| +10% | – | ﹤0.01% | 245 |
|
|
2020
Q2 | $502K | Hold |
19,700
| – | – | 0.15% | 128 |
|
|
2020
Q1 | $305K | Buy |
+19,700
| New | +$305K | 0.11% | 169 |
|